Pompe disease, a rare genetic disorder caused by the deficiency of the enzyme acid alpha-glucosidase, has seen remarkable progress in treatment options over the years. Several pharmaceutical companies have taken on the challenge of developing innovative therapies to address the symptoms and improve the quality of life for individuals with Pompe disease. In this article, we will explore some of...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek